Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-08-31
1992-06-30
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514287, 514242, 514254, 514269, 514272, 514273, 514274, 544297, 544182, 544238, 544300, 544310, 544316, 544317, 544319, 544320, 544322, 544324, 544327, 544328, 544331, 544361, 546 64, 546 65, 546 82, 546 83, A61K 3138, A61K 31435, C07D23928, C07D49104
Patent
active
051263521
ABSTRACT:
Novel polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives are disclosed which are useful for treatment allergic reactions, inflammation, peptic ulcers, hypertension, and hyperproliferative skin diseases and for suppressing the immune response in mammals. Methods for preparing said compounds are also disclosed.
REFERENCES:
patent: 3931199 (1976-01-01), Nakaishi et al.
patent: 3931205 (1976-01-01), Nakanishi et al.
patent: 3947449 (1976-03-01), Durchkheimer et al.
patent: 4596809 (1986-06-01), Sherlock
patent: 4680297 (1987-07-01), Blythin et al.
patent: 4680298 (1987-07-01), Blythin
patent: 4687774 (1987-08-01), Smith et al.
patent: 4760073 (1988-07-01), Blythin et al.
patent: 4801589 (1989-01-01), Smith et al.
patent: 4882332 (1989-11-01), Siegel et al.
Fournier et al., Bulletin De La Societe Chimique De France, 1968, No. 1, pp. 364-369.
Derwent Abstract of Japanese published application J5 8144-391A, 1980.
Chem. Ab., vol. 96: No. 217821K, (1980).
Hawkins et al., Chem. Soc. Perkins Tans. I, 1983, pp. 2077-2087.
Chem. Ab., vol. 85, No. 108567; p. 455 (1976).
Chemical Abstracts, vol. 101, Abstract No. 38382t, 1984.
Chem. Abstracts, 91(5):32785e, (1979), p. 33.
Bernath et al., J. Heterocycl. Chem., 16(1), 137-44 (1979).
Chem. Abstracts, 88(13):89668m, (1978), p. 522.
Chem. Abstracts, 85(3):2137x, (1976), p. 695.
Chem. Abstracts, 74(15):74797q, (1971), p. 303.
Chem. Abstracts, 85(7):46621m, (1976), p. 536.
Chem. Abstracts, 90(25):203821z, (1979), pp. 600-601.
Chem. Abstracts, 93(5):46364v, (1980), p. 902.
Chem. Abstracts, 95(13):115339w, (1981), p. 686.
Chem. Abstracts, 80(19):108503g, (1974), p. 419.
Chem. Abstracts, 82(1):4230r, (1976), pp. 367-368.
Chem. Abstracts, 88(19):130847j, (1978), p. 32.
Chem. Abstracts, 93(19):186323f, (1980), p. 863.
Chem. Abstracts, 88(3):22701y, (1978), p. 617.
Chem. Abstracts, 87(17):127017n, (1977), p. 28.
Chem. Abstracts, 84(9):59429j, (1976), p. 522.
Chem. Abstracts, 67(9):43655t, (1976), pp. 428-431.
Chem. Abstracts, 97(11):92173n, (1982), p. 761.
Chem. Abstracts, 86(7):43594q, (1977), p. 536.
Chem. Abstracts, 91(15):123609s, (1979), p. 588.
Chem. Abstracts, 98:215861n, (1983), p. 584.
Chem. Abstracts, 69:67264q, (1968), 6280-6281.
Khim-Farm Zh., 10(5), pp. 18-22 (1976).
Chem. Ab., 70, (1969), No. 77902y, pp. 348-349.
Zh. Obshch. Khim., 38(9), pp. 2051-2064 (1968).
Australian J. Chem., vol. 27, pp. 1295-1308, D. J. Gale (1977).
Liebigs Annalen der Chemie, (1984), F. Eiden, pp. 1759-1777.
Chem. Abstracts, 91(5):32785e, (1979), p. 33.
Friary Richard J.
Ganguly Ashit K.
Schwerdt John H.
Seidl Vera A.
Siegel Marvin I.
Blasdale John H. C.
Nelson James R.
Richter Johann
Schering Corporation
LandOfFree
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1864034